Positives

• Patients with cutaneous sporotrichosis describe significant improvement on SSKI, with one case report showing lesions reduced by at least 50 percent within a month of treatment Wiley.
  
  
• SSKI has been used as effective adjunctive therapy for mucormycosis in COVID-era cases, allowing shortened amphotericin courses ScienceDirect.
  
  

Negatives

• Patients commonly describe SSKI as poorly tolerated due to bitter metallic taste, nausea, vomiting, and stomach pain that often forces dose reductions Life-Worldwide.
  
  
• One case report describes a patient developing subclinical hypothyroidism from SSKI use, attributed to the Wolff-Chaikoff effect PMC.
  
  

Hurdles & Side Effects

• SSKI is documented for sporotrichosis and certain mold infections, not candida or yeast dysbiosis, so off-label use lacks supporting evidence Life-Worldwide.
  
  
• Patients with thyroid disease, iodine sensitivity, or on lithium and amiodarone face significant interaction and toxicity risks with SSKI Life-Worldwide.